Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TGA Of Australia Probes Adverse Flu-Vaccine Effects In Youngest Kids

This article was originally published in PharmAsia News

Executive Summary

Australia's Therapeutic Goods Administration has launched a probe into whether the seasonal flu vaccine is safe for children under five years of age. The nation's chief medical officer advised physicians to cease giving the shots to children in that age group after seeing a sharp increase in adverse reactions in West Australia. The reports said the young children often experienced fever and convulsions in response to the inoculations. The vaccine was made by Australia's CSL, which has been asked by authorities to identify the batches sent to the Australian state and to test them. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC074645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel